v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue        
Revenue $ 22,574 $ 28 $ 22,589 $ 81
Operating expenses:        
Cost of Revenue 10,060 15 10,070 45
Research and development (including related party purchases of $512 and $247 for the three months ended September 30, 2025 and 2024, respectively, $1,235 and $796 for the nine months ended September 30, 2025 and 2024, respectively.) 149,163 126,139 419,837 354,771
Selling, general and administrative (including related party purchases of $70 and $37 for the three months ended September 30, 2025 and 2024, respectively, $172 and $122 for the nine months ended September 30, 2025 and 2024, respectively.) 45,018 30,569 105,497 92,144
Total operating expenses 204,241 156,723 535,404 446,960
Loss from operations (181,667) (156,695) (512,815) (446,879)
Interest and other income, net 9,673 9,528 29,420 33,038
Loss on common stock issuance in private placement 0 0 (40,258) 0
Gain (Loss) from change in fair value of warrants and earnout shares (229,149) 3,842 (284,424) 52,683
Total other income (loss), net (219,476) 13,370 (295,262) 85,721
Loss before income taxes (401,143) (143,325) (808,077) (361,158)
Income tax expense 83 553 229 599
Net loss $ (401,226) $ (143,878) $ (808,306) $ (361,757)
Net loss per share, basic (in dollars per share) $ (0.48) $ (0.21) $ (1.01) $ (0.53)
Net loss per share, diluted (in dollars per share) $ (0.48) $ (0.21) $ (1.01) $ (0.53)
Weighted-average common stock outstanding, basic (in shares) 844,551,006 695,011,457 803,188,296 688,718,075
Weighted-average common stock outstanding, diluted (in shares) 844,551,006 695,011,457 803,188,296 688,718,075

Source